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foamy cells and sclerotic areas. Numerous thickened and
hyalinized blood vessels were evident throughout the tumor
tissue. No mitotic figure was observed. Neoplastic cells
were diffusely immunoreactive for S100 protein, focally
positive for GFAP, and negative for α-smooth muscle actin,
desmin, CD34, CD117 and AE1/AE3 cytokeratins. Ki-67
proliferation index was 3%. Histological diagnosis was of
cellular schwannoma. Discussion and Conclusion:
Schwannomas are benign soft tissue tumors that originate
from the peripheral nerve sheath. Their most common sites
are head and neck region and extremities, whereas the
retroperitoneal location is rare, accounting for 0.3 to 3.2%
of all schwannomas (2). MRI with gadolinium enhancement
has been advocated as superior to computed tomography in
highlighting cystic degeneration, defining margins and
identifying the point of origin from the nerve (1).
Retrospective evaluation of MRI in our case allowed to
confirm this assessment and to identify the possible origin
of the lesion from the genitofemoral nerve. Definitive
diagnosis can only be made by histopathological
examination with immunohistochemical confirmation (1),
but preoperative fine needle aspiration diagnosis may be
performed (2). According to a recent report, retroperitoneal
schwannoma often occurs in middle-aged women, exhibits
cellular subtype features and extensively expresses GFAP
(3). Except for the classification in the cellular subtype, our
case does not confirm such observation, showing only
limited areas of GFAP positivity and occurring in a young
adult male patient.
1 Choudry HA, Nikfarjam M, Liang JJ, Kimchi ET, Conter
R, Guani NJ and Staveley O’Carroll KF: Diagnosis and
management of retroperitoneal ancient schwannomas. W J
Surg Oncol 7: 12, 2009.
2 Kudo T, Kawakami H, Kuwatani M, Ehira N, Yamato H, Eto
K, Kubota K and Asaka M: Three cases of retroperitoneal
schwannoma diagnosed by EUS-FNA. W J Gastroenterol
17: 3459-3464, 2011.
3 Hirose T, Ishizawa K, Sakaki M and Fujii Y: Retroperitoneal
schwannoma is characterized by a high incidence of cellular
type and GFAP-immunoreactivity. Pathol Int 62: 456462,
2012.
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Introduction and Aim: Actually only a few preoperative
systems are available to predict malignancy or aggresiveness
of a renal mass, and all of them suffer from a low predictive
accuracy. Recentely, Kutikov et al. (1) generated a
nomogram based on R.E.N.A.L. score, that showed a
predictive accuracy higher than 70%. The aim of this study
was to perform an external validation of this predictive tool
on a cohort of patients submitted to partial nephrectomy.
Methods: Agile is a collaborative group of Italian young
(<40 yrs) urologists with a specific interest in mini-invasive
surgery. Since 2011 the group perspectively shared and
compiled a database to collect the data of all the patients
undergoing open, laparoscopic or robotic partial
nephrectomy. Among the data, also R.E.N.A.L. score has
been calculated in its attributes by an urologist blinded of the
final pathology. After the centralization of database, the
nomogram proposed by Kutikov has been applied to each
case, using the online calculator available at
www.cancernomograms.com, to calculate the predicted
probability of malignancy and aggressiveness. A logistic
regression model has been used to estimate the correlation
of each of the parameters included into the nomogram and
the final pathology. Results: The data of 294 patients have
been collected (185 male, 109 female, age 63±12 yrs),
submitted to open (197 patients), laparoscopic (28) or robotic
(69) partial nephrectomy. Histology was benign in 60 cases
(21.6%), malignant in 234 (79.4%); among malignant cases,
was aggressive - high grade - in 34 (17.9%), not aggressive
in 144 (82.1%). Mean total R.E.N.A.L. score was 5.8±1.6.
The Tables present the results of statistical analysis that
estimate the correlation of the parameters included into the
nomogram with malignancy (Table I) or aggressiveness
(Table II) at final pathology (in bold correlation with
statistical significance).
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Table I. Statistical correlation between characteristics and
malignant histology.
p RR (95% CI)
Age (yrs) 0.364 1.011 (0.988-1.034)
Male gender 0.010 2.138 (1.203-3.798)
Nephrometry sum 0.217 1.129 (0.931-1.368)
R attribute 0.303
1 referent
2 0.544 1.252 (0.606-2.588)
3 0.175 0.347 (0.075-1.603)
E attribute 0.376
1 referent
2 0.326 1.371 (0.731-2.572)
3 0.265 2.360 (0.521-10.689)
N attribute 0.322
1 referent
2 0.685 1.262 (0.410-3.889)
3 0.141 2.524 (0.737-8.644)
L attribute 0.049
1 referent
2 0.021 2.471 (1.145-5.332)
3 0.924 0.968 (0.498-1.881)
involvement of renal sinus
no referent
yes 0.347 0.59 (0.201-1.758)
Table II. Statistical correlation between characteristics and high
grade RCC.
p RR (95% CI)
Age (yrs) 0.364 1.011 (0.988-1.034)
Male gender 0.010 2.138 (1.203-3.798)
Nephrometry sum 0.217 1.129 (0.931-1.368)
R attribute 0.303
1 referent
2 0.544 1.252 (0.606-2.588)
3 0.175 0.347 (0.075-1.603)
E attribute 0.376
1 referent
2 0.326 1.371 (0.731-2.572)
3 0.265 2.360 (0.521-10.689)
N attribute 0.322
1 referent
2 0.685 1.262 (0.410-3.889)
3 0.141 2.524 (0.737-8.644)
L attribute 0.049
1 referent
2 0.021 2.471 (1.145-5.332)
3 0.924 0.968 (0.498-1.881)
Involvement of renal sinus
no referent
yes 0.347 0.59 (0.201-1.758)
The malignancy rate predicted by the nomogram for benign
and malignant tumors was 79.2% and 80.3%, respectively
(AUC 0.541, p=0.326); the predicted aggressiveness rate for
non aggressive and aggressive renal cancer was 30.9% and
38.6%, respectively (AUC 0.660, p=0.004). Conclusion:
Conversely to the cohort in which the nomogram has been
generated – that included also advanced or metastatic tumors
– the present study aims at validating the nomogram on a
cohort of cases submitted to partial nephrectomy, in which
the prediction of malignancy or aggressiveness could be
more clinically important because these masses could be
amenable of ablation or observation. The nomogram showed
a poor predictive ability for malignancy, whereas a discrete
accuracy for aggressiveness, mainly due to a strong
relationship with the diameter of the tumor. Since the
external validation failed, the nomogram should be re-
calibrated on a cohort of small renal masses.
1 Kutikov A, Smaldone MC, Egleston BL et al: Anatomic
features of enhancing renal masses predict malignant and
high-grade pathology: a preoperative nomogram using the
RENAL Nephrometry score. Eur Urol 60(2): 241-248, 2011.
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Introduction: To evaluate whether splitting TURP and Hifu
in two sessions can reduce complication rate in patients with
localized prostate cancer. Patients and Methods: From
November 2004 to November 2012, 118 patients affected by
localized prostate cancer underwent HIFU following TURP.
In 39 patients both procedures were performed in the same
session (Group A); in 79 patients HIFU was delayed (Group
B). Follow up included serial PSA measurements and
prostate biopsies 6 months after the treatment in all patients.
Biochemical recurrence was defined as PSA nadir + 2 ng/ml
(ASTRO 2005 criteria). We have evaluated complication rate
in the Group A and B. Results: The mean age, PSA and
prostate volume were 78.9 years, 8.7 ng/ml and 31 cc,
respectively. Mean procedure time was 127 minutes and
mean hospitalization was 3.8 days. Complication rate was
not associated with clinical stage (T1 vs. T2) (p<0.6),
Gleason score (p<0.5), age (p<0.2), prostate volume
(p<0.06), PSA (p<0.9). Complications rate was lower when
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